UK-US trade deal will mean the NHS has to divert billions from other services to pay more for new medicines

Article excerpt

Around £45 billion in NHS funding will be diverted from other NHS care by 2036 to pay more for new medicines under the UK-U.S. trade deal agreed last December unless more funding is made available to cover the additional costs, suggests an analysis published by The BMJ .